Merck 2010 Annual Report Download - page 11

Download and view the complete annual report

Please find page 11 of the 2010 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 223

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • 221
  • 222
  • 223

Merck is pursuing a business model aimed at creating value for shareholders and owners.
Following the acquisition of Millipore, we have a portfolio with a balanced distribution of risk.
This portfolio is based on core competences in three businesses with synergetic potential:
pharmaceuticals, chemicals and life science.
Merck runs its operating business in four divisions: Merck Serono, Consumer Health Care,
Merck Millipore and Performance Materials.
The Merck Serono division markets prescription medicines. It discovers, develops and manufactures
both chemical and biological molecules. Merck holds strong positions in neurodegenerative
diseases and oncology. In addition, the division markets fertility treatments, a field in which
we are the world market leader, and growth hormones as well as a broad portfolio of classic
products, especially for cardiovascular and metabolic disorders.
The Consumer Health Care division offers over-the-counter products for preventive health care
and the self-treatment of minor ailments.
Merck is the global leader in the liquid crystals market. Besides the display materials business,
the Performance Materials division focuses on lighting materials for energy-saving LEDs (light-
emitting diodes) and OLEDs (organic LEDs). Pigments for the plastics, printing and coatings
industries as well as for cosmetic applications are also an important part of the Performance
Materials portfolio. Moreover, the division is the market leader for pearl luster effect pigments
– a highly specialized niche within the pigment market.
In 2010, Merck acquired the U.S. life science company Millipore. Founded in 1954 by Jack Bush,
the focus at that time was on filtration technology for water treatment and laboratories. This
enabled Millipore to achieve a breakthrough worldwide. Later on, further businesses such as
bioprocessing and bioanalytical services for the pharmaceutical industry were added, trans-
forming Millipore into a leading global life science company.
With the acquisition of Millipore, Merck is now a leading life science company. The Merck Mil-
lipore division offers products for life science research such as assays, biomarkers and target
solutions, as well as bioprocessing, lab water purification and filtration. Additionally, the divi-
sion supplies specialty chemicals mainly to regulated markets, for example the pharmaceutical,
cosmetics and food industries. Analytical and scientific laboratories use our reagents and test
kits. In total, the Merck Millipore portfolio comprises more than 40,000 products and processes.
Merck will continue to focus on specialty products in its pharmaceutical, chemical and life
science businesses while creating synergies. We will also further invest significantly in research
and development while pursuing growth both organically and through acquisitions. We will
adhere to our very solid finance policy.
7Corporate governance Consolidated Financial Statements More information
Company Management Report